C. Sautès-Fridman

Oncology · 2010–2022

A researcher in the Science corpus: 10 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom C. Sautès-Fridman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Robert Schreiber

Who trusts C. Sautès-Fridman overall

  1. Ton N. Schumacher
  2. D. Thommen
  3. Beth A. Helmink

Papers from C. Sautès-Fridman's perspective

Ordered by how strongly the researchers C. Sautès-Fridman trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (Nature Medicine)
  2. Hallmarks of cancer: the next generation. (Cell)
  3. Cancer immunoediting: from immunosurveillance to tumor escape (Nature Immunology)
  4. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  5. Effector memory T cells, early metastasis, and survival in colorectal cancer. (New England Journal of Medicine)
  6. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. (Journal of Clinical Oncology)
  7. Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes (Clinical Cancer Research)
  8. Cancer-related inflammation (Nature)
  9. Cancer despite immunosurveillance: immunoselection and immunosubversion (Nature reviews. Immunology)
  10. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. (Cancer Research)

Their papers